Familial failure of hepatitis B immunization

Journal of Pediatric Gastroenterology and Nutrition

Volumn 23, Issue 3, 1996, Pages 307-311

  Del Rosario, J Fernando ^a   Orenstein, Susan R ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; CYCLOSPORIN; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; ECHOGRAPHY; FEMALE; GRAFT REJECTION; HEPATITIS B; HEPATITIS NON A NON B; HUMAN; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; LABORATORY TEST; LIVER BIOPSY; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVACCINATION; SERODIAGNOSIS; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT FAILURE;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CHILD, PRESCHOOL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; INTERFERON-ALPHA; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; VACCINES, SYNTHETIC;

NON-A, NON-B HEPATITIS VIRUS;

EID: 0029795411     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199610000-00017     Document Type: Article

References (29)

1. Hadler SC, Margolis HS. Hepatitis B immunization: vaccine types, efficacy, and indications for immunization. Curr Clin Topics Infect Dis 1992;12:282-308.
2. Peter G, ed. Summaries of infections diseases. 1994 red book: report of the Committee on Infectious Diseases. 23rd ed. Elk Grove Village. IL: American Academy of Pediatrics, 1994:224-38.
3. Emini EA, Ellis RW, Miller WJ, McAleen WJ, Scolnick EM, Gerety RJ. Production and immunological analysis of recombinant hepatitis B vaccine. J Infect 1986;13(suppl A): 3-9.
4. Stephenne J. Development and production aspects of a recombinant yeast-derived hepatitis B vaccine. Vaccine 1990;8(S):S69-73.
5. Keyserling HL, West DJ, Hesley TM, Bosley C, Wiens BL, Calandra GB. Antibody responses of healthy infants to a recombinant hepatitis B vaccine administered at two, four, and twelve or fifteen months of age. J Pediatr 1994;125:67-9.
6. Jilg W, Schmidt M, Deinhardt F. Vaccination against hepatitis B: comparison of three different vaccination schedules. J Infect Dis 1989;160:766-9.
7. CDC. Suboptimal response to hepatitis B vaccine given by injection into the buttock. MMWR 1985;34:105-8.
8. Ukena T, Esber H, Bessette R, Parks T, Crocker B. Site of injection and response to hepatitis B vaccine. N Engl J Med 1985;313:579-80.
9. Reid AE, Friedman LS. Immunity to hepatitis B virus: passing the torch. Gastroenterology 1994;106:1388-94.
10. Collier AC, Corey L, Murphy VL, Handsfield HH. Antibody to human immunodeficiency virus and suboptimal response to hepatitis B vaccination. Ann Intern Med 1988;109: 101-5.
11. Hadler SC. Hepatitis B prevention and human immunodeficiency virus infection. Ann Intern Med 1988;109:92-4.
12. Stevens CE, Alter HJ, Taylor PE, et al. Hepatitis B vaccine in patients receiving hemodialysis: immunogenicity and efficacy. N Engl J Med 1984;311:496-501.
13. Wagner D, Wagenbreth I, Stachnan-Kunstyr R, Flik J. Failure of vaccination against hepatitis B with Gen H-B-Vax-D in immunosuppressed heart transplant recipients. Clin Invest 1992;70:585-7.
14. Sokal EM, Ulla L, Otte JB. Hepatitis B vaccine response before and after transplantation in 55 extrahepatic biliary atresia children. Dig Dis Sci 1992;37:1250-2.
15. Van Thiel DH, El-Ashmawy L, Love K, Gavaler JS, Starzl TE. Response to hepatitis B vaccination by liver transplant candidates. Dig Dis Sci 1992;37:1245-9.
16. Lykavieris P, Fabre M, Yvart J, Alvarez F. HBV infection in pediatric liver transplantation. J Pediatr Gastroenterol Nutr 1993;16:321-7.
17. Alper CA, Kruskall MS, Marcus-Bagley D, et al. Genetic predisposition of nonresponse to hepatitis B vaccine. N Engl J Med 1989;21:708-12.
18. Carman WF, Zanetti A, Karayiannis P, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336: 325-9.
19. Carman WF, Thomas H, Domingo E. Viral genetic variation: hepatitis B virus as a clinical example. Lancet 1993; 341:349-53.
20. Li L, Sheng MH, Tong SP, Chen HZ, Wen YM. Transplacental transmission of hepatitis B virus. Lancet 1986;2:872.
21. Foster GR, Goldin RD, Hay A, McGarvey MJ, Stark GR, Thomas HC. Expression of the terminal protein of hepatitis B virus is associated with failure to respond to interferon therapy. Hepatology 1993;17:757-62.
22. Pignatelli M, Waters J, Brown D, et al. HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection. Hepatology 1986;6:349-53.
23. Perrillo RP. Interferon therapy for chronic type B hepatitis: the promise comes of age. Gastroenterology 1989;96:532-6.
24. Brunetto M, Oliveri F, Rocca Giuseppe, et al. Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen. Hepatology 1989;10:198-202.
25. Ruiz-Moreno M, Rua MJ, Molina J, et al. Prospective, randomized controlled trial of interferon-α in children with chronic hepatitis B. Hepatology 1991;13:1035-9.
26. 2a-interferon: a controlled, randomized study. Am J Gastroenterol 1991;86:327-30.
27. Lok ASF, Ma OCK, Lau JYN. Interferon alfa therapy in patients with chronic hepatitis B virus infection: effects on hepatitis B virus DNA in the liver. Gastroenterology 1991; 100:756-61.
28. Lok ASF, Chung HT, Liu VWS, Ma OCK. Long-term follow-up of chronic hepatitis B patients treated with interferon alfa. Gastroenterology 1993;105:1833-8.
29. Availability of interferon alfa-2b follows successful clinical trials. Issues Hepatitis 1992;2(2):1-3.